Living Cell Technologies Ltd (LCT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Living Cell Technologies Ltd (LCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7362
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson’s disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington’s, Alzheimer’s and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT’s joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd (LCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Living Cell Technologies Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Living Cell Technologies to Raise Funds through Share Purchase Plan 10
Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 11
Acquisition 12
Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 12
Living Cell Technologies Ltd – Key Competitors 13
Living Cell Technologies Ltd – Key Employees 14
Living Cell Technologies Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Recent Developments 17
Financial Announcements 17
Jul 26, 2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018 17
Aug 23, 2017: Living Cell Technologies: Preliminary Final Report 30 June 2017 18
Jul 20, 2017: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2017 19
Corporate Communications 20
Aug 31, 2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post 20
Other Significant Developments 21
Apr 11, 2018: LCT Strategy Update 21
Oct 18, 2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Living Cell Technologies Ltd, Medical Equipment, Key Facts, 2018 2
Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Living Cell Technologies Ltd, Deals By Market, 2012 to YTD 2018 8
Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Living Cell Technologies to Raise Funds through Share Purchase Plan 10
Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 11
Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 12
Living Cell Technologies Ltd, Key Competitors 13
Living Cell Technologies Ltd, Key Employees 14
Living Cell Technologies Ltd, Subsidiaries 15
Living Cell Technologies Ltd, Joint Venture 16

List of Figures
Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Living Cell Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Living Cell Technologies Ltd (LCT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corona Remedies Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Corona Remedies Pvt Ltd (Corona) is a drugs manufacturing company that develops, manufactures, and markets pharmaceutical products. The company’s products include antiallergic drugs, antibiotic drugs, analgesic drugs, antimalarial drugs, heamatonics, hormonal drugs, nutritional supplements, …
  • Exxon Mobil Corporation:企業のM&A・事業提携・投資動向
    Exxon Mobil Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exxon Mobil Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Monotype Imaging Holdings Inc (TYPE):企業の財務・戦略的SWOT分析
    Summary Monotype Imaging Holdings Inc (Monotype Imaging) is a technology company, which offers text imaging solutions. The company’s products include embedded solutions and olapic earned content platform. Its solutions comprise imaging solutions for print, web and mobile environments. Monotype Imagi …
  • MetLife, Inc.:企業のM&A・事業提携・投資動向
    MetLife, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MetLife, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • FPT Industrial SpA:企業の戦略的SWOT分析
    FPT Industrial SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Center For Diagnostic Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Center For Diagnostic Imaging Inc (CDI), a subsidiary of InSight Health Services Holdings Corp is a healthcare center that patient care services. The center offers upright MRI, diagnostic breast imaging exams, breast biopsies, open CDI vascular care, open upright MRI, nuclear medicine, ultra …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chemical Company of Malaysia Bhd (CCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Chemical Company of Malaysia Bhd (CCM) is an industrial and specialty chemicals company. It manufactures and markets chlor-alkali and coagulant products; markets industrial and specialty chemicals; and produces polymer coating. The company’s chemical offerings find application in petrochemic …
  • The Mosaic Company:企業の戦略・SWOT・財務情報
    The Mosaic Company - Strategy, SWOT and Corporate Finance Report Summary The Mosaic Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Helomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East Eng …
  • Boralex Inc (BLX):企業の財務・戦略的SWOT分析
    Boralex Inc (BLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Eurobio Scientific SA (ALEHT):企業の財務・戦略的SWOT分析
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. …
  • BPER Banca Spa:企業のM&A・事業提携・投資動向
    BPER Banca Spa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPER Banca Spa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • EnviTec Biogas AG (ETG):企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • OSRAM Licht AG:企業のM&A・事業提携・投資動向
    OSRAM Licht AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OSRAM Licht AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Surgical Specialties Corp:企業の戦略・SWOT・財務分析
    Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report Summary Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • QBE Insurance Group Limited:戦略・SWOT・企業財務分析
    QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆